Scholars Central

Conference abstractPublished 2015

Feasibility and tolerability of Vardhamaan Pippali Rasayan and other Rasayan drugs with DOT (Direct Obesrved Treatment) in patient of tuberculosis under RNTCP

Authors: Kore Sharayu A, Shubhangi Jadhav, Gayatri Kulkarni

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In the world of herbal drugs, Ayurveda has achieved the highest position. Presently, it is one of the most popular ancient science in complimentary therapy. The scenario of Ayurveda has changed from treating only very chronic diseases and some cosmetology related problems to global health challenges like HIV and tuberculosis. The efficacy of modern medicines also has some grey areas such as side effects, untowards or adverse effect which compel the patient to discontinue the treatment. Thus, inspite of availablity of effective treatment the prevelance of disease is rising. HIV along with tuberculois aggravates the problem. WHO has reccommonded to give supportive therapy which will be useful to reduce side effects like gastritis or severe muscular weakness felt on the day of taking DOT medicines. Sane Guruji Arogya Kendra is an authorised DOT centre where average 25 to 30 newly diagnosed cases of tuberculosis come annually. With the objective of reducing the side effects of the DOT the patients have been given supplimentary Ayurvedic medicines as mentioned above along with DOT. In awide range of patients, it was observed that side effects were very well controlled. The obsevations were encouraging and thought provoking. Both the drugs were very well tolarated. Patient showed tremendous improvement in apetite, gained weight, had better quality of life. The detail analysis of data showed that the given supplimentary therapy proved to be beneficial. It is recommonded to take up multicentric trial based on this work. This can be a step towards contribution of Ayurveda to National health programme.

Subjects

Chemistry

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalNatural Products Chemistry & Research
  • SubjectChemistry
  • BylineArticles whose byline prints “Kore Sharayu A”
  • BylineArticles whose byline prints “Shubhangi Jadhav”
  • BylineArticles whose byline prints “Gayatri Kulkarni”